DPI - Dry Powder Inhalers
»
»
»

 Latest News 

Analytica 2012
Germany, Munich
17.-20.04.2012
Visit us at hall A1, booth no. 303

24-Oct-11

Achema 2012

Germany, Frankfurt
18.-22.06.2012
Visit us at hall 4.1, booth no. F

24-Oct-11

ERWEKA dissolution vessels are interchangeable
  • within a dissolution tester*
  • between dissolution tester*
  • all requirements regarding the FDA „Mechanical Calibration“ are fulfilled

29-Mar-11

Sales Meeting successfully finished
From 11.-13.10.2010 ERWEKA staff members and dealers

28-Oct-10

Conical Mill
  • for product infeed system
  • application for developmen

01-Jun-10

 News Archive
June 2010
TBH 525 (01-Jun-10)March 2010
ERWEKA launches new products at Analytica (09-Mar-10)December 2009
ERWEKA Scholarship granted in China for the third year (07-Dec-09)
 
DPI - Dry Powder Inhalers » Single Stage Glass Impinger Glaxo (EP App. A)

Single Stage Glass Impinger Glaxo (EP App. A)


The unit operates on the principle of liquid impingement to divide the dose emitted from the inhaler into the non-respirable dose impacting on the mouth and oropharynx wich is swallowed and the remaining respirable dose.
The apparatus is relatively simple, easy to use and rugged in construction and is ideal for routine Quality Control applications. The Glass Single Stage Impinger comes complete with base plate and appropriate clamps, bossheads and fittings as standard.


«